Published in Hum Vaccin on January 21, 2006
Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming 'vaccine resistant malaria'. Parasite Immunol (2009) 2.17
Recombinant peptide replicates immunogenicity of synthetic linear peptide chimera for use as pre-erythrocytic stage malaria vaccine. Microbes Infect (2008) 0.87
Analysis of a Multi-component Multi-stage Malaria Vaccine Candidate--Tackling the Cocktail Challenge. PLoS One (2015) 0.86
Baculovirus-vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites. Infect Immun (2014) 0.85
Immune responses of mice with different genetic backgrounds to improved multiepitope, multitarget malaria vaccine candidate antigen FALVAC-1A. Clin Vaccine Immunol (2008) 0.79
Discovery of gene function by expression profiling of the malaria parasite life cycle. Science (2003) 10.57
Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet (2002) 4.13
Zoonotic potential and molecular epidemiology of Giardia species and giardiasis. Clin Microbiol Rev (2011) 3.45
Subgenotype analysis of Cryptosporidium isolates from humans, cattle, and zoo ruminants in Portugal. J Clin Microbiol (2003) 3.03
The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. Am J Trop Med Hyg (2004) 3.00
Reduction of malaria during pregnancy by permethrin-treated bed nets in an area of intense perennial malaria transmission in western Kenya. Am J Trop Med Hyg (2003) 2.97
Unique endemicity of cryptosporidiosis in children in Kuwait. J Clin Microbiol (2005) 2.84
Cryptosporidium hominis n. sp. (Apicomplexa: Cryptosporidiidae) from Homo sapiens. J Eukaryot Microbiol (2002) 2.75
The United States Trypanosoma cruzi Infection Study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors. Transfusion (2012) 2.69
A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children. Lancet (2002) 2.69
Triosephosphate isomerase gene characterization and potential zoonotic transmission of Giardia duodenalis. Emerg Infect Dis (2003) 2.46
Distribution of cryptosporidium genotypes in storm event water samples from three watersheds in New York. Appl Environ Microbiol (2005) 2.27
Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles. J Infect Dis (2006) 2.26
A monkey's tale: the origin of Plasmodium vivax as a human malaria parasite. Proc Natl Acad Sci U S A (2005) 2.25
Host adaptation and host-parasite co-evolution in Cryptosporidium: implications for taxonomy and public health. Int J Parasitol (2002) 2.21
Cryptosporidium tyzzeri n. sp. (Apicomplexa: Cryptosporidiidae) in domestic mice (Mus musculus). Exp Parasitol (2011) 2.16
Molecular characterization of microsporidia indicates that wild mammals Harbor host-adapted Enterocytozoon spp. as well as human-pathogenic Enterocytozoon bieneusi. Appl Environ Microbiol (2003) 2.15
The efficacy of permethrin-treated bed nets on child mortality and morbidity in western Kenya I. Development of infrastructure and description of study site. Am J Trop Med Hyg (2003) 2.13
Common origin and fixation of Plasmodium falciparum dhfr and dhps mutations associated with sulfadoxine-pyrimethamine resistance in a low-transmission area in South America. Antimicrob Agents Chemother (2007) 2.08
Three drinking-water-associated cryptosporidiosis outbreaks, Northern Ireland. Emerg Infect Dis (2002) 2.04
Impact of permethrin-treated bed nets on malaria, anemia, and growth in infants in an area of intense perennial malaria transmission in western Kenya. Am J Trop Med Hyg (2003) 2.03
Real-time fluorescence loop mediated isothermal amplification for the diagnosis of malaria. PLoS One (2010) 2.02
Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India. Malar J (2008) 2.00
Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. Malar J (2007) 1.97
Origin and evolution of sulfadoxine resistant Plasmodium falciparum. PLoS Pathog (2010) 1.96
Cryptosporidium species and subtypes and clinical manifestations in children, Peru. Emerg Infect Dis (2008) 1.96
Identification of novel Cryptosporidium genotypes from the Czech Republic. Appl Environ Microbiol (2003) 1.93
Genome sequence diversity and clues to the evolution of variola (smallpox) virus. Science (2006) 1.84
Assessing the effect of natural selection in malaria parasites. Trends Parasitol (2004) 1.78
Molecular epidemiology of cryptosporidiosis in children in Malawi. J Eukaryot Microbiol (2003) 1.75
Prevalence and age-related variation of Cryptosporidium species and genotypes in dairy calves. Vet Parasitol (2004) 1.75
Dynamics of malaria drug resistance patterns in the Amazon basin region following changes in Peruvian national treatment policy for uncomplicated malaria. Antimicrob Agents Chemother (2009) 1.74
Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design. Proc Natl Acad Sci U S A (2009) 1.72
Development of procedures for direct extraction of Cryptosporidium DNA from water concentrates and for relief of PCR inhibitors. Appl Environ Microbiol (2005) 1.68
Modulation of immune responses during HIV-malaria co-infection in pregnancy. Trends Parasitol (2005) 1.67
Pyrosequencing, a high-throughput method for detecting single nucleotide polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum. J Clin Microbiol (2006) 1.61
Molecular surveillance of Cryptosporidium spp., Giardia duodenalis, and Enterocytozoon bieneusi by genotyping and subtyping parasites in wastewater. PLoS Negl Trop Dis (2012) 1.60
Molecular phylogeny and evolutionary relationships of Cryptosporidium parasites at the actin locus. J Parasitol (2002) 1.56
South American Plasmodium falciparum after the malaria eradication era: clonal population expansion and survival of the fittest hybrids. PLoS One (2011) 1.55
Differences in clinical manifestations among Cryptosporidium species and subtypes in HIV-infected persons. J Infect Dis (2007) 1.53
Multilocus sequence typing and genetic structure of Cryptosporidium hominis from children in Kolkata, India. Infect Genet Evol (2006) 1.52
Wide geographic distribution of Cryptosporidium bovis and the deer-like genotype in bovines. Vet Parasitol (2006) 1.51
Fatal myositis due to the microsporidian Brachiola algerae, a mosquito pathogen. N Engl J Med (2004) 1.51
Zoonotic Cryptosporidium species and Enterocytozoon bieneusi genotypes in HIV-positive patients on antiretroviral therapy. J Clin Microbiol (2012) 1.51
HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites. PLoS Med (2007) 1.49
Molecular characterization of Enterocytozoon bieneusi in cattle indicates that only some isolates have zoonotic potential. Parasitol Res (2004) 1.47
Molecular surveillance of Cryptosporidium spp. in raw wastewater in Milwaukee: implications for understanding outbreak occurrence and transmission dynamics. J Clin Microbiol (2003) 1.46
Decline in sulfadoxine-pyrimethamine-resistant alleles after change in drug policy in the Amazon region of Peru. Antimicrob Agents Chemother (2007) 1.43
Primary amebic meningoencephalitis deaths associated with sinus irrigation using contaminated tap water. Clin Infect Dis (2012) 1.41
Epidemiology of Enterocytozoon bieneusi Infection in Humans. J Parasitol Res (2012) 1.41
Concurrent infections of Giardia duodenalis, Enterocytozoon bieneusi, and Clostridium difficile in children during a cryptosporidiosis outbreak in a pediatric hospital in China. PLoS Negl Trop Dis (2013) 1.41
Cryptosporidium genotypes in wildlife from a new york watershed. Appl Environ Microbiol (2007) 1.39
Giardiasis in dogs and cats: update on epidemiology and public health significance. Trends Parasitol (2010) 1.39
Direct comparison of selected methods for genetic categorisation of Cryptosporidium parvum and Cryptosporidium hominis species. Int J Parasitol (2005) 1.38
Geographic variation in the sensitivity of recombinant antigen-based rapid tests for chronic Trypanosoma cruzi infection. Am J Trop Med Hyg (2009) 1.38
Genetic diversity of Cryptosporidium spp. in cattle in Michigan: implications for understanding the transmission dynamics. Parasitol Res (2003) 1.37
Identification of the cryptosporidium pig genotype in a human patient. J Infect Dis (2002) 1.36
pfmdr1 amplification and fixation of pfcrt chloroquine resistance alleles in Plasmodium falciparum in Venezuela. Antimicrob Agents Chemother (2010) 1.36
Burden of malaria in pregnancy in Jharkhand State, India. Malar J (2009) 1.36
Cryptosporidium sp. rabbit genotype, a newly identified human pathogen. Emerg Infect Dis (2009) 1.35
Cryptosporidium species and genotypes in HIV-positive patients in Lima, Peru. J Eukaryot Microbiol (2003) 1.34
Hitchhiking and selective sweeps of Plasmodium falciparum sulfadoxine and pyrimethamine resistance alleles in a population from central Africa. Antimicrob Agents Chemother (2008) 1.34
Distribution of Cryptosporidium subtypes in humans and domestic and wild ruminants in Portugal. Parasitol Res (2006) 1.34
The epidemiology of intestinal microsporidiosis in patients with HIV/AIDS in Lima, Peru. J Infect Dis (2005) 1.33
Genetic characterizations of Cryptosporidium spp. and Giardia duodenalis in humans in Henan, China. Exp Parasitol (2010) 1.32
Applied genomics: data mining reveals species-specific malaria diagnostic targets more sensitive than 18S rRNA. J Clin Microbiol (2011) 1.32
A biologic basis for integrated malaria control. Am J Trop Med Hyg (2002) 1.30
Treatment history and treatment dose are important determinants of sulfadoxine-pyrimethamine efficacy in children with uncomplicated malaria in Western Kenya. J Infect Dis (2003) 1.30
Extended outbreak of cryptosporidiosis in a pediatric hospital, China. Emerg Infect Dis (2012) 1.30
Burden of cerebral malaria in central India (2004-2007). Am J Trop Med Hyg (2008) 1.29
Cyclospora papionis, Cryptosporidium hominis, and human-pathogenic Enterocytozoon bieneusi in captive baboons in Kenya. J Clin Microbiol (2011) 1.28
Subtyping Cryptosporidium ubiquitum,a zoonotic pathogen emerging in humans. Emerg Infect Dis (2014) 1.28
A molecular biologic study of Enterocytozoon bieneusi in HIV-infected patients in Lima, Peru. J Eukaryot Microbiol (2003) 1.27
Cryptosporidiosis in developing countries. J Infect Dev Ctries (2007) 1.27
Selective sweeps and genetic lineages of Plasmodium falciparum drug -resistant alleles in Ghana. J Infect Dis (2011) 1.26
Occurrence of human-pathogenic Enterocytozoon bieneusi, Giardia duodenalis and Cryptosporidium genotypes in laboratory macaques in Guangxi, China. Parasitol Int (2013) 1.25
Anthroponotic enteric parasites in monkeys in public park, China. Emerg Infect Dis (2012) 1.25
Genetic variations in the internal transcribed spacer and mitochondrial small subunit rRNA gene of Naegleria spp. J Eukaryot Microbiol (2003) 1.24
Distribution of Giardia duodenalis genotypes and subgenotypes in raw urban wastewater in Milwaukee, Wisconsin. Appl Environ Microbiol (2004) 1.24
Immunization with pre-erythrocytic antigen CelTOS from Plasmodium falciparum elicits cross-species protection against heterologous challenge with Plasmodium berghei. PLoS One (2010) 1.24
A study of genetic diversity in the gene encoding the circumsporozoite protein (CSP) of Plasmodium falciparum from different transmission areas--XVI. Asembo Bay Cohort Project. Mol Biochem Parasitol (2002) 1.24
Evaluation of three PCR-based diagnostic assays for detecting mixed Plasmodium infection. BMC Res Notes (2010) 1.23
Detection and differentiation of Cryptosporidium parasites that are pathogenic for humans by real-time PCR. J Clin Microbiol (2002) 1.23
Genetic polymorphism and zoonotic potential of Enterocytozoon bieneusi from nonhuman primates in China. Appl Environ Microbiol (2014) 1.22
Immunity to placental malaria. IV. Placental malaria is associated with up-regulation of macrophage migration inhibitory factor in intervillous blood. J Infect Dis (2002) 1.22